The Diaceutics Podcast
🎙️ The Diaceutics Podcast: Diagnostics, Data & Commercial Strategy Welcome to The Diaceutics Podcast — where diagnostics meet data, and strategy meets impact. In each episode, we explore how Diaceutics is helping pharma and biotech companies navigate the complex journey from biomarker discovery to therapy adoption. Whether it’s oncology, rare disease, or emerging therapeutic areas, we dive into the real-world challenges and innovations shaping the future of healthcare. From diagnostic testing and commercialization to AI, real-time data, and global market access — this is your front-row seat to the evolving world of precision-driven healthcare. www.diaceutics.com
Listen on:
Episodes
4 days ago
4 days ago
Join Susanne Munksted, Chief Precision Medicine Officer at Diaceutics, and Kevin Entwistle, VP of Precision Medicine Strategy, as they unpack the key takeaways from ASCO 2025 and explore how the latest oncology data can shape your commercial strategy.
In this expert-led discussion, you'll hear about:
How to translate scientific insights into actionable strategies for pharma and biotech teams
Commercial implications of novel ADCs, gene & cell therapies, and multi-cancer detection
The growing impact of AI and computational pathology in clinical decision-making
Breakthrough clinical data from trials like SERENA-6, MATTERHORN, ATOMIC, and AMPLITUDE
Advances in ctDNA and MRD detection, including MONSTAR-SCREEN-3 and DYNAMIC-III
The evolving role of biomarkers and diagnostic testing in precision medicine
Connect with the Speakers
Susanne Munksted: https://www.linkedin.com/in/susanne-munksted-9169031/
Kevin Entwistle: https://www.linkedin.com/in/kevin-entwistle-73335520/
🌐 Learn more about Diaceutics: https://www.diaceutics.com/contact-us